Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus

US7041692B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Timothy Herpin · Princeton, US
• Gregory S. Bisacchi · Lawrenceville, US
• Zulan Pi · Pennington, US
• E. Scott Priestley · Hockessin, US
• T. G. Murali Dhar · Newtown, US

Key dates

• Filing date: Jun 17, 2003
• Grant date: May 9, 2006
• Expiry date: Aug 9, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Methods of treating Factor VIIa-associated conditions in a mammal are described, comprising administering to the mammal in need of treatment thereof an effective amount of at least one compound having the formula (I),or a pharmaceutically-acceptable salt, hydrate or prodrug thereof.